Solara Active Pharma Sciences Share Price
Small Cap | Pharmaceuticals and health care | NSE: SOLARA | BSE: 541540
₹490.15 
23.30 (4.99 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 480.00
High (₹) 490.15
Low (₹) 465.00
Prev. Close (₹) 466.85
Volume 13,136
VWAP (₹) 479.05
ROCE (%) -17.42
Industry P/E 43.99
TTM P/E -7.81
P/B Ratio 1.89
Market Cap (₹) Cr.1,976.87
Dividend Yield (%)--
EPS (₹) -157.62
ROE-60.59%
Sales Growth (%) -10.73
Profit Growth (%)2,448.13
Day Range
490.15490.15
52 Week Range
360.23885.95
Historical Returns
Returns (6M)
-31.52 %
Returns (1Y)
8.85 %
Returns (3Y)
-25.17 %
Returns (5Y)
-24.08 %
Returns (6M)
-31.52 %
Returns (1Y)
8.85 %
Returns (3Y)
-25.17 %
Returns (5Y)
-24.08 %
SWOT Analysis
- Company with (2458.77%) TTM EPS Growth
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 47.72
MFI 27.59
ATR 26.40
Commodity Channel Index -103.26
ROC125 -33.14
ROC21 -21.02
Williams %R -64.08
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 498.54 | 506.92 | 523.69 | 481.77 | 473.39 | 456.62 | 448.24 |
| Week Ago | 509.19 | 528.12 | 544.24 | 493.07 | 474.14 | 458.02 | 439.09 |
| Month Ago | 704.96 | 735.58 | 753.11 | 687.43 | 656.81 | 639.28 | 608.66 |
EMA & SMA
490.15
Current Price
Bullish Moving Averages
1
Bearish Moving Averages
19
5 Day 490.25
9 Day 497.69
10 Day 501.87
12 Day 509.74
14 Day 511.11
20 Day 507.72
26 Day 551.20
50 Day 617.19
100 Day 698.52
200 Day 641.29
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| AGNUS HOLDINGS PRIVATE LIMITED | bulk | Sell | 06 Dec, 2023 | ₹335.90 | 2,72,181 | BSE |
| SPIRACCA VENTURES LLP | bulk | Buy | 06 Dec, 2023 | ₹336.00 | 3,07,772 | BSE |
| KARUNA BUSINESS SOLUTIONS LLP | bulk | Sell | 06 Sept, 2023 | ₹367.46 | 7,36,253 | BSE |
| SPIRACCA VENTURES LLP | bulk | Buy | 06 Sept, 2023 | ₹367.46 | 7,36,253 | BSE |
| KARUNA BUSINESS SOLUTIONS LLP | bulk | Sell | 26 Jun, 2023 | ₹374.35 | 1,99,553 | BSE |
| SPIRACCA VENTURES LLP | bulk | Buy | 26 Jun, 2023 | ₹374.35 | 1,99,553 | BSE |
| UNNATI MANAGEMENT CONSULTANTS LLP | bulk | Sell | 11 Feb, 2022 | ₹674.05 | 2,67,022 | BSE |
| REDDYVANGA VENTURES LLP | bulk | Buy | 11 Feb, 2022 | ₹674.05 | 2,67,022 | BSE |
| ONTARIO PENSION BOARD | block | Sell | 20 Dec, 2021 | ₹1,077.95 | 1,83,474 | BSE |
| IMCO EMERGING MARKETS PUBLIC EQUITY LP | block | Buy | 20 Dec, 2021 | ₹1,077.95 | 1,83,474 | BSE |
| ONTARIO PENSION BOARD | bulk | Sell | 20 Dec, 2021 | ₹1,077.95 | 1,83,474 | BSE |
| IMCO EMERGING MARKETS PUBLIC EQUITY LP | bulk | Buy | 20 Dec, 2021 | ₹1,077.95 | 1,83,474 | BSE |
| TPG GROWTH IV SF PTE LTD | block | Sell | 10 May, 2021 | ₹1,557.26 | 13,36,495 | BSE |
| PRONOMZ VENTURES LLP | block | Sell | 10 May, 2021 | ₹1,552.05 | 1,99,588 | BSE |
| CLASSIC OPPORTUNITIES FUND ULIF 033 16 12 09 CLAOPPFND 107 | block | Buy | 10 May, 2021 | ₹1,552.05 | 2,57,823 | BSE |
| ADITYA BIRLA SUN LIFE MUTUAL FUND | block | Buy | 10 May, 2021 | ₹1,552.05 | 1,94,000 | BSE |
| ADITYA BIRLA SUN LIFE FLEXI CAP FUND | block | Buy | 10 May, 2021 | ₹1,552.05 | 3,90,000 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 14 Feb, 2025 | Pronomz Ventures LLP | Acquisition | ₹524.8245588235294117647058824 | 34,000 | BSE |
| 05 Feb, 2025 | Pronomz Ventures LLP | Acquisition | ₹516.6833461538461538461538462 | 78,000 | BSE |
| 27 Sept, 2024 | Ramakrishnan R | Acquisition | ₹808.30 | 3,000 | BSE |
| 26 Sept, 2024 | Ramakrishnan R | Acquisition | ₹773.25 | 2,000 | BSE |
| 27 Dec, 2023 | Devicam Capital LLP | Disposal | ₹339.6506999141401576265538819 | 20,13,747 | BSE |
| 08 Dec, 2023 | Karuna Business Solutions LLP | Disposal | ₹335.1160124750639206540979461 | 35,591 | BSE |
| 08 Dec, 2023 | Agnus Holdings Private Limited | Disposal | ₹334.2158012499035568243191112 | 2,72,181 | BSE |
| 08 Dec, 2023 | Karuna Ventures Private Limited | Disposal | ₹333.0721039163811423862601379 | 92,228 | BSE |
| 08 Sept, 2023 | Karuna Business Solutions LLP | Disposal | ₹365.6237000052970921680454952 | 7,36,253 | BSE |
| 31 Aug, 2023 | R RAMAKRISHNAN | Disposal | ₹366.116 | 500 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 05 Jul, 2023 | Rights issue of equity shares of Rs. 10/- in the ratio of 1:3 @ premium of Rs. 365/-. | 15 May, 2024 | 15 May, 2024 |
| 06 May, 2021 | Rs.3.0000 per share(30%)Dividend | 18 Aug, 2021 | 01 Jan, 1970 |
| 06 Nov, 2020 | Rs.4.0000 per share(40%)Interim Dividend | 19 Nov, 2020 | 20 Nov, 2020 |
| 07 May, 2020 | Rs.2.0000 per share(20%)Dividend | 28 Jul, 2020 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 21 Feb, 2025 | BSE India | Solara Active Pharma Sciences Limited has informed the Exchange about Grant of ESOP Options. |
| 21 Feb, 2025 | BSE India | Solara Active Pharma Sciences Limited has informed the Exchange regarding the Closure of Wholly Owned Subsidiary of the Company. |
| 21 Feb, 2025 | BSE India | Solara Active Pharma Sciences Limited has informed the Exchange regarding Resignation of Managing Director. |
| 21 Feb, 2025 | BSE India | Solara Active Pharma Sciences Limited has informed the Exchange regarding Appointment and Resignation of Chief Executive officer, Appointment and Resignation of Chief Financial Officer, Appointment of a Senior Managerial Personnel. |
| 21 Feb, 2025 | BSE India | Solara Active Pharma Sciences has informed the Exchange regarding the appointment of a Managing Director. |
| 21 Feb, 2025 | BSE India | Solara Active Pharma Sciences Limited has informed the Exchange regarding Board meeting held on February 21, 2025 interalia to consider Appointment and resignation of MD & CEO, Appointment and resignation of CFO and Appointment of Senior Management Personnel, Reconstitution of Committees, Closure of Wholly owned subsidiary and Grant of ESOP options |
| 10 Feb, 2025 | NSE India | Monitoring Agency Report for the quarter ended December 31, 2024 received from CRISIL Ratings Limited is being submitted |
| 10 Feb, 2025 | BSE India | Monitoring Agency Report for the quarter ended December 31, 2024 received from CRISIL Ratings Limited is being submitted. |
| 07 Feb, 2025 | NSE India | SOLARA: The Company in their Board Committee Meeting held today (i.e) February 07, 2025, considered the proposal to incorporate a Wholly Owned Subsidiary Company. |
| 07 Feb, 2025 | BSE India | The Company in their Board Committee meeting held today (i.e.) February 07, 2025, considered the proposal to Incorporate a wholly - owned subsidiary Company. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 17 Jan, 2025 | 24 Jan, 2025 |
| Quarterly Results | -- | 15 Oct, 2024 | 21 Oct, 2024 |
| Quarterly Results | -- | 16 Jul, 2024 | 22 Jul, 2024 |
| Audited Results | -- | 22 May, 2024 | 29 May, 2024 |
| To consider Fund Raising | -- | 08 May, 2024 | 09 May, 2024 |
| Quarterly Results | -- | 06 Feb, 2024 | 14 Feb, 2024 |
| Quarterly Results | -- | 09 Nov, 2023 | 14 Nov, 2023 |
| Quarterly Results | (Revised) | 09 Aug, 2023 | 14 Aug, 2023 |
| Quarterly Results | -- | 09 Aug, 2023 | 11 Aug, 2023 |
| Right issue of Equity Shares | -- | 01 Jul, 2023 | 05 Jul, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Solara Active Pharma Sciences
Solara Active Pharma Sciences is a Public Limited Listed company incorporated on 23/02/2017 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH2017PLC291636 and registration number is 291636. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1288.92 Cr. and Equity Capital is Rs. 36.00 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Strides Group
Founded
2017
Managing Director
Mr. Poorvank Purohit
NSE Symbol
SOLARA
Solara Active Pharma Sciences Management
| Name | Designation |
|---|---|
| Mr. R Ramakrishnan | Chairman & Ind.Director |
| Mr. Poorvank Purohit | Managing Director & CEO |
| Mr. Mohan Muthunarayanan | COO & Executive Director |
| Mr. Manish Gupta | Non Executive Director |
| Mr. Kartheek Chintalapati Raju | Non Executive Director |
| Mr. Arun Kumar | Non Executive Director |
| Dr. Kausalya Santhanam | Independent Director |
| Mr. Rajiv Vijay Nabar | Independent Director |
| Mr. Rajendra Kumar Srivastava | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Solara Active Pharma Sciences
What is the share price of Solara Active Pharma Sciences?
The share price of Solara Active Pharma Sciences on 21 Feb, 2025 is ₹ 490.15.
What is 52W high and 52W low share price of Solara Active Pharma Sciences?
The highest and lowest 52W share prices of Solara Active Pharma Sciences are ₹ 885.950 and ₹ 355.725
What is the market cap of Solara Active Pharma Sciences?
The market capitalization of Solara Active Pharma Sciences as of 21 Feb, 2025 is ₹ 1,976.87 Crores
What is the P/E ratio of Solara Active Pharma Sciences?
The current P/E ratio of Solara Active Pharma Sciences as of 21 Feb, 2025 is 43.99
What is the PB ratio of Solara Active Pharma Sciences?
The PB ratio of Solara Active Pharma Sciences as of 21 Feb, 2025 is 1.89
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)